An Open Label Study to Evaluate the Safety of Xeloda as Adjuvant Monotherapy in Patients Who Have Undergone Surgery for Colon Cancer, Dukes Stage C.

Trial Profile

An Open Label Study to Evaluate the Safety of Xeloda as Adjuvant Monotherapy in Patients Who Have Undergone Surgery for Colon Cancer, Dukes Stage C.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Sep 2015

At a glance

  • Drugs Capecitabine (Primary)
  • Indications Colon cancer
  • Focus Adverse reactions
  • Sponsors Roche
  • Most Recent Events

    • 06 Jul 2012 Actual patient number is 230 according to ClinicalTrials.gov.
    • 06 Jul 2012 Planned End Date changed from 1 Apr 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 06 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top